Enveric Biosciences Celebrates and Supports 2023 Mental Health Awareness Month – Medical Marijuana Program Connection

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced its support of Mental Health Awareness Month this May as the company advances its novel development programs to improve the treatment of mental health disorders. Anxiety disorders continue to be a large unmet need, affec

Source link